Effectiveness of Manual Therapy and Exercise in Shoulder OA

Effectiveness of Manual Therapy and Exercise in the Management of Glenohumeral Osteoarthritis: A Randomized Controlled Trial

Approximately 60 subjects from a sample of convenience diagnosed with shoulder arthritis will be randomized into a two groups. The control group will receive usual medical advice and the experimental group will be referred to physical therapy for eight visits over 4-week period of time. At one month, two months, and one year the pain, function, and patient satisfaction will be compared between the two groups.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

This study will be a pragmatic, prospective, single blind, randomized controlled trial. Stratified randomization will be performed to account for those patients that necessitate a subacromial corticosteroid injection prior to or during the physical therapy intervention. The diagnosis of primary glenohumeral osteoarthritis will be confirmed by the orthopedic surgeon involved in the study. All subjects will have radiographs at the time of initial evaluation (standard medical practice) and magnetic resonance imaging will only be required at the discretion of the orthopedic surgeon when this modality is necessary to rule out other shoulder pathologies of concern.

This study will use a convenient sample of consecutive subjects who meet all inclusion criteria and present to the shoulder service physicians at UT Southwestern outpatient clinic with a primary compliant of shoulder pain and stiffness. If appropriate for the study, the subjects will be referred to physical therapy for additional assessment and care. If interested in participation, each potential subject will be educated regarding the purpose and logistics of the study and asked to enroll via informed consent.

Approximately 25 of the 50 subjects will be seen in the clinic for 6 visits within a 4 week time frame. All subjects will return for follow-up or phone call at 4, 8, and 52 weeks for final data collection and outcomes assessment. The last follow-up assessment at one year will be via phone contact. For those attending physical therapy, the duration of the visits, 1-6, will last from 30-60 min. The final visit, visit 9, will take 15-30 minutes. The phone call on the tenth interaction will last 5-10 minutes.

Session 1: Participant Enrollment - Obtainment of consent, HIPPA and health screen. Baseline dependent variable data will be collection and the subjects will be randomly allocated to one of the treatment groups. One group will receive usual medical advice including tips on posture, activity modifications, and symptom control. The other group will initiate the program of physical therapy outlined below. Subjects allocated to the physical therapy treatment arm will proceed to a standard physical therapy visit in which they will be instructed in the initial exercise training and educated on the use exercise log for assessment of compliance.

Session 2-6 (within 4 weeks after session 1): All patients in the experimental group will receive standardized physical therapy intervention to treat shoulder osteoarthritis including manual therapy (no more than 2 units, <37 minutes) and standard flexibility and range of motion exercises. Patient's will also undergo an in clinic assessment of compliance of their exercise program and appropriate progression of the shoulder strengthening exercises will be provided. Patients in the control group will not participate in sessions 2-5.

Independent Variable:

Group 1 Intervention- manual physical therapy and strengthening exercises to the entire upper quarter, flexibility exercises, range of motion exercises, and usual medical advice.

Manual Therapy: joint mobilization to anterior, posterior, and inferior capsule as indicated at discretion of treating physical therapist

Shoulder Exercise Training:

  1. Adducted ER with towel roll in sitting or standing ("no-money" exercise with concurrent external rotation)
  2. Supine or standing boxer punch for serratus
  3. Short arc military press progressing to flexion or scaption as tolerated
  4. Subscapularis isolation via seated narrow grip internal rotation row
  5. Horizontal abduction in neutral (wide grip rows)

    • Compliance to the home exercise program will be assessed using a daily log.
    • All therapeutic exercises with include theraband resistance performed 2-3x20/daily

Session 6 (4 weeks after Session 1): Post-Intervention Data Collection and finalization of the exercise training and self-mobilization protocol for the experimental group. The control group will return for a repeat of baseline testing.

Session 7 (8 weeks after Session 1): Post-Intervention Data Collection - Re-assessment of dependent variables.

Session 8 (one year after enrollment): Phone call to collect outcome assessment data

Dependent Variables:

Primary

  1. Numerical pain rating scale at baseline day 28, day 56, and day 365 during scapular plane shoulder elevation
  2. Functional Outcome Score: American Shoulder and Elbow Surgeon scale (ASES) questionnaire and Simple Shoulder Test (SST)

Secondary

  1. Patient's Global Rating of Change (15 point ordinal scale ranging from -7 to +7)
  2. Patient self-reported global percentage of improvement (0-100%)
  3. Tampa Scale for Kinesiophobia score
  4. Pittsburgh Sleep Quality Index score
  5. Internal and External Rotation Range of Motion
  6. Scapular Elevation strength via manual muscle test

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Dallas, Texas, United States, 76039
        • UT Southwestern Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • over 50 years of age
  • Osteoarthritis > Grade 3 on the Kellgren-Lawrence scale
  • Presence of at least two of the following findings:
  • morning stiffness that resolves within 60 minutes
  • pain > 3/10 on a numerical pain rating scale
  • asymmetrical mobility in either contralateral elevation and/or glenohumeral rotation, or notable crepitus with active motion.

Exclusion Criteria:

  • medical co-morbidities (diabetes and rheumatoid arthritis)
  • adhesive capsulitis
  • fractures
  • scapulothoracic paresis
  • surgery in past year
  • inability to speak English language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
usual medical advice regarding symptomatic control and activity modification
Experimental: Experimental
Six visits of physical therapy to provide manual therapy and therapeutic exercise
application of manual therapy techniques to upper extremity along with therapeutic exercise procedures to the axioscapular and rotator cuff musculature

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Level Change
Time Frame: change in function from baseline to two months
self-report outcome score via American Shoulder Elbow Surgeon's scale and Simple Shoulder Test
change in function from baseline to two months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Global Rating of Change
Time Frame: change in rating from baseline to two months
scale of patient satisfaction
change in rating from baseline to two months
Pittsburgh Sleep Quality Index
Time Frame: change in sleep quality from baseline to two months
sleep quality assessment
change in sleep quality from baseline to two months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Patricia Smith, PhD, UT Southwestern Medical Center
  • Principal Investigator: Edward Mulligan, DPT, UT Southwestern Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2016

Primary Completion (Anticipated)

June 1, 2019

Study Completion (Anticipated)

June 1, 2020

Study Registration Dates

First Submitted

October 20, 2015

First Submitted That Met QC Criteria

October 23, 2015

First Posted (Estimate)

October 27, 2015

Study Record Updates

Last Update Posted (Actual)

September 13, 2019

Last Update Submitted That Met QC Criteria

September 10, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 042015-091

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis

Clinical Trials on physical therapy

Subscribe